Advocacy intelligence hub — real-time data for patient organizations
Parathar: FDA approved
Diagnostic agent to assist in establishing the diagnosis in patients presenting with clinical and laboratory evidence of hypocalcemia due to either hypoparathyroidism or pseudohypoparathyroidism.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Parathar
Rhone-Poulenc Rorer Pharmaceuticals, Inc.
Browse all NON RARE IN EUROPE: Chronic proteinuria with focal and segmental hyalinosis news →
View all NON RARE IN EUROPE: Chronic proteinuria with focal and segmental hyalinosis specialists →